Skip to main content
. 2019 Feb 14;11(2):220. doi: 10.3390/cancers11020220

Figure 1.

Figure 1

Stellettin B affects the viability of glioblastoma cell lines. (A) U87MG and GBM8401 cells were treated with 0, 1, 5, 10, 25, 50, or 100 µM stellettin B for 24 or 48 h. Cell viability was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Data are presented as mean ± standard deviation (SD) (n = 3). * p < 0.05 relative to controls. (B) Morphology of U87MG and GBM8401 cells after treatment with 0, 1, 5, or 10 µM stellettin B for 24 or 48 h. Cells were observed using phase-contrast microscopy. Scale bars, 25 μm.